Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PYPD | US
-0.06
-1.37%
Healthcare
Biotechnology
30/06/2024
10/04/2026
4.31
4.28
4.41
4.26
PolyPid Ltd. a clinical-stage pharmaceutical company develops manufactures and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100 which helps in the prevention of sternal (bone) surgical site infections (SSIs) as well as for the prevention of abdominal (soft tissue) SSIs. It is also developing OncoPLEX for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva Israel.
View LessStrong Sharpe Ratio (> 1.2)
Negative Momentum (Declining Price)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
40.8%1 month
46.8%3 months
44.8%6 months
43.0%-
-
14.58
6.89
0.56
-0.36
-
-
-21.95M
29.32M
29.32M
-
-
-
-
-496.62
1.89
0.13
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.42
Range1M
0.66
Range3M
1.11
Rel. volume
0.78
Price X volume
186.67K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Rafael Holdings Inc | RFL | Biotechnology | 1.26 | 31.10M | -3.82% | n/a | 2.77% |
| Kiromic BioPharma Inc | KRBP | Biotechnology | 19.77 | 30.56M | n/a | -258.59% | |
| Cue Biopharma Inc | CUE | Biotechnology | 0.5019 | 30.22M | 71.36% | n/a | 52.09% |
| Audentes Therapeutics Inc | BOLD | Biotechnology | 1.13 | 29.60M | -0.88% | n/a | 0.47% |
| Plus Therapeutics Inc | PSTV | Biotechnology | 4.8 | 28.30M | 22.45% | n/a | -45.04% |
| CELU | CELU | Biotechnology | 1.27 | 27.92M | -6.62% | n/a | 127.38% |
| Inovio Pharmaceuticals Inc | INO | Biotechnology | 1.06 | 27.52M | 0.95% | n/a | 13.42% |
| Atara Biotherapeutics Inc | ATRA | Biotechnology | 4.65 | 26.81M | -3.73% | n/a | -81.03% |
| Dyadic International Inc | DYAI | Biotechnology | 0.8908 | 26.26M | 1.71% | n/a | 175.64% |
| Mustang Bio Inc | MBIO | Biotechnology | 0.7 | 26.06M | -5.79% | n/a | -13.03% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 11.76 | 17.91M | 6.72% | n/a | 204.46% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.08 | 15.78M | -6.90% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.601 | 11.61M | -7.68% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.34 | 3.42M | 3.08% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.2536 | 2.41M | -15.10% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.09 | 1.15M | 7.18% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.006 | 553.29K | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.36 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 14.58 | 15.55 | Par |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 44.82 | - | Lower Risk |
| Debt to Equity | 6.89 | -1.23 | Expensive |
| Debt to Assets | 0.56 | 0.25 | Expensive |
| Market Cap | 29.32M | - | Emerging |